4:36 PM
 | 
Nov 06, 2018
 |  BC Extra  |  Company News

Management tracks: Five Prime, Alder

Five Prime Therapeutics Inc. (NASDAQ:FPRX) hired David Smith as EVP and CFO, effective Nov. 26. He will replace Linda Rubinstein, who was interim CFO of the cancer company. Smith was COO of IntegenX Inc. until its acquisition this year by Thermo Fisher Scientific Inc. (NYSE:TMO).

Metabolic company Jnana Therapeutics Inc. (Boston, Mass.) named co-founder and President Joanne Kotz as CEO. She succeeds board member Amir...

Read the full 303 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >